These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38683970)

  • 1. Machine Learning-Based Prediction of Reduction Potentials for Pt
    Vigna V; Cova TFGG; Nunes SCC; Pais AACC; Sicilia E
    J Chem Inf Model; 2024 May; 64(9):3733-3743. PubMed ID: 38683970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding intrinsically irreversible, non-Nernstian, two-electron redox processes: a combined experimental and computational study of the electrochemical activation of platinum(IV) antitumor prodrugs.
    McCormick MC; Keijzer K; Polavarapu A; Schultz FA; Baik MH
    J Am Chem Soc; 2014 Jun; 136(25):8992-9000. PubMed ID: 24853204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues.
    Chen S; Yao H; Zhou Q; Tse MK; Gunawan YF; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11676-11687. PubMed ID: 32799457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pt(IV) complexes as prodrugs for cisplatin.
    Shi Y; Liu SA; Kerwood DJ; Goodisman J; Dabrowiak JC
    J Inorg Biochem; 2012 Feb; 107(1):6-14. PubMed ID: 22169035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Activity, Reduction Mechanism and G-Quadruplex DNA Binding of a Redox-Activated Platinum(IV)-Salphen Complex.
    Vigna V; Scoditti S; Spinello A; Mazzone G; Sicilia E
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cancer cell killing of a Pt(IV) prodrug promoted by outer-sphere coordination with polyethyleneimines.
    Garaikoetxea Arguinzoniz A; Gómez Blanco N; Ansorena Legarra P; Mareque-Rivas JC
    Dalton Trans; 2015 Apr; 44(16):7135-8. PubMed ID: 25812853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
    Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
    Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid.
    Dabbish E; Ponte F; Russo N; Sicilia E
    Inorg Chem; 2019 Mar; 58(6):3851-3860. PubMed ID: 30843385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of the reduction products of platinum(IV) prodrugs upon the configuration of the substrate, bulk of the carrier ligands, and nature of the reducing agent.
    Sinisi M; Intini FP; Natile G
    Inorg Chem; 2012 Sep; 51(18):9694-704. PubMed ID: 22921246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum(IV) Prodrugs.
    Venkatesh V; Sadler PJ
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394022
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Tsipis AC; Karapetsas IN
    Magn Reson Chem; 2017 Jul; 55(7):662-669. PubMed ID: 28002879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes.
    Corinti D; Crestoni ME; Fornarini S; Dabbish E; Sicilia E; Gabano E; Perin E; Osella D
    J Biol Inorg Chem; 2020 Jun; 25(4):655-670. PubMed ID: 32296997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes.
    Bolitho EM; Sanchez-Cano C; Shi H; Quinn PD; Harkiolaki M; Imberti C; Sadler PJ
    J Am Chem Soc; 2021 Dec; 143(48):20224-20240. PubMed ID: 34808054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status in computational exploration of Pt(IV) prodrug activation by reduction.
    Ponte F; Scoditti S; Mazzone G; Sicilia E
    Phys Chem Chem Phys; 2023 Jun; 25(23):15586-15599. PubMed ID: 37259840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
    Xu Z; Chan HM; Li C; Wang Z; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2018 Jul; 57(14):8227-8235. PubMed ID: 29943979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting
    Ondar EE; Polynski MV; Ananikov VP
    Chemphyschem; 2023 Jun; 24(11):e202200940. PubMed ID: 36806426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrodrugs: an electrochemical prodrug activation strategy.
    Norman DJ; González-Fernández E; Clavadetscher J; Tucker L; Staderini M; Mount AR; Murray AF; Bradley M
    Chem Commun (Camb); 2018 Aug; 54(66):9242-9245. PubMed ID: 30066701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling.
    Gramatica P; Papa E; Luini M; Monti E; Gariboldi MB; Ravera M; Gabano E; Gaviglio L; Osella D
    J Biol Inorg Chem; 2010 Sep; 15(7):1157-69. PubMed ID: 20526854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
    Yap SQ; Chin CF; Hong Thng AH; Pang YY; Ho HK; Ang WH
    ChemMedChem; 2017 Feb; 12(4):300-311. PubMed ID: 28028938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.